PTC Therapeutics
Develops and commercializes treatments for patients with rare diseases
Company facts
- Founded
- 1998
- Employees
- 1,047
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: PTCT
- Subsidiaries
- Censa Pharmaceuticals, Agilis Biotherapeutics, PTC Therapeutics International Ltd